What Is Mast Cell Activation Syndrome (MCAS)?

Mast cell activation syndrome (MCAS) is a condition in which mast cells, a type of immune cell found throughout your body, release their chemical contents too easily and too often. Unlike allergies, where a specific trigger sets off a predictable reaction, MCAS involves mast cells firing inappropriately in response to a wide range of stimuli, producing symptoms across multiple organ systems. The result can look like severe allergic reactions, digestive problems, skin flares, and neurological symptoms, sometimes all at once.

What Mast Cells Do and Why It Matters

Mast cells are part of your immune system’s first line of defense. They sit in tissues throughout your body, especially in skin, the lining of your gut, and your airways, ready to respond to threats. When activated, they release preformed packets of chemical mediators within seconds to minutes. The most well-known of these is histamine, but mast cells also release enzymes called proteases, inflammatory signaling molecules, and lipid-based compounds like prostaglandins and leukotrienes.

These chemicals do useful things in normal amounts: they increase blood flow to an injured area, help white blood cells reach an infection, and trigger mucus production to trap inhaled pathogens. But in MCAS, the release is disproportionate to any real threat. Histamine alone can cause flushing, increased heart rate, nasal congestion, gut cramping, and airway constriction. Layer on the effects of prostaglandins and leukotrienes, and you get a wide, unpredictable symptom profile that can shift from day to day.

How MCAS Differs From Mastocytosis

MCAS is sometimes confused with mastocytosis, but the two conditions are fundamentally different. In mastocytosis, the body produces too many mast cells. Dense clusters of mast cells infiltrate the bone marrow, skin, or other organs. A bone marrow biopsy in mastocytosis typically shows aggregates of more than 15 mast cells packed together.

In MCAS, the number of mast cells is normal. The problem is behavior, not quantity. A bone marrow biopsy in someone with MCAS usually comes back completely normal. The mast cells simply activate when they shouldn’t, releasing their chemical contents in response to triggers that wouldn’t bother most people. Both conditions can produce overlapping symptoms, but the underlying pathology and long-term management differ.

Symptoms Across the Body

Because mast cells live in nearly every tissue, MCAS can produce symptoms in virtually any organ system. The hallmark of MCAS is that symptoms affect at least two different organ systems, which is part of what makes it so difficult to diagnose. Many people see specialists for years before the pattern is recognized.

Skin symptoms are among the most common and visible. These include flushing (sudden redness and heat, typically in the face, neck, and chest), hives, intense itching, and angioedema, which is deeper swelling of the face, lips, eyelids, tongue, or throat.

Gastrointestinal symptoms often include abdominal pain, bloating, nausea, vomiting, diarrhea, constipation, or an alternating pattern of both. Acid reflux is also common. Respiratory symptoms range from nasal congestion and itching to wheezing, shortness of breath, and throat swelling. Neurological symptoms can include headaches, brain fog, difficulty concentrating, anxiety, depression, light-headedness, and fainting. In severe cases, a combination of these symptoms can escalate into anaphylaxis.

Common Triggers

One of the most frustrating aspects of MCAS is the sheer variety of things that can set off a reaction. Triggers vary widely between individuals and can even change over time in the same person. Common categories include temperature extremes (both heat and cold), physical exertion, emotional stress, certain foods (especially those high in histamine or that promote histamine release), alcohol, medications, insect stings, fragrances, and chemical exposures.

Some people find that triggers are additive. A single exposure might not cause symptoms, but two or three minor triggers on the same day can push mast cells past their threshold. This stacking effect makes it hard to pin down what’s causing a flare, since the culprit may be the combination rather than any single exposure.

How MCAS Is Diagnosed

Diagnosis follows consensus criteria that require all three of the following: recurrent severe symptoms involving at least two organ systems that are consistent with mast cell mediator release; improvement of symptoms with medications that block mast cell mediators; and laboratory evidence of elevated mast cell markers during at least two separate episodes.

The preferred lab marker is serum tryptase, an enzyme released by activated mast cells. Because everyone has a different baseline tryptase level, clinicians look for a rise above your personal baseline rather than a single absolute number. The established threshold is an increase of more than 20% plus 2 ng/mL above your baseline, sometimes called the “20 plus 2 rule.” Blood for tryptase testing needs to be drawn within about four hours of symptom onset, which creates a practical challenge since many people aren’t near a lab when a flare hits.

When tryptase testing isn’t feasible or results are inconclusive, 24-hour urine collections can measure other mast cell byproducts, including a histamine breakdown product called N-methylhistamine, a prostaglandin metabolite, and leukotriene E4. Elevated levels of any of these during symptomatic episodes support the diagnosis.

Meeting all three criteria can take months or longer, especially because flares are unpredictable and lab timing is tricky. Some clinicians will start treatment based on strong clinical suspicion while continuing to document the required lab evidence.

Treatment and Symptom Management

Treatment for MCAS focuses on blocking or reducing the effects of the chemicals mast cells release. There is no cure, but most people can achieve meaningful symptom control with a combination of medications.

The foundation of treatment is a two-pronged antihistamine approach. H1 antihistamines (the type you’d take for seasonal allergies, like cetirizine, loratadine, or fexofenadine) target itching, flushing, hives, abdominal pain, headaches, and brain fog. H2 antihistamines (like famotidine, commonly known as Pepcid) address gastrointestinal symptoms and provide additional mast cell stabilization. Both types are considered necessary because they block different histamine receptors on the mast cell surface. If acid reflux persists despite H2 antihistamines, a proton pump inhibitor can be added, but it doesn’t replace the H2 blocker.

Beyond antihistamines, several other medication classes help. Mast cell stabilizers like oral cromolyn sodium can reduce gut symptoms and brain fog by preventing mast cells from releasing their contents in the first place. Leukotriene inhibitors help with respiratory symptoms and provide broader mast cell stabilization. For people with elevated prostaglandin levels, carefully supervised aspirin therapy can reduce flushing, brain fog, and bone pain, though aspirin itself can be a trigger for some MCAS patients.

Trigger avoidance plays a major role alongside medication. Many people keep symptom diaries to identify their personal triggers and learn to manage exposure. Some find that a low-histamine diet reduces baseline symptoms enough to make flares less frequent and less severe. The goal of treatment is to lower the overall “mediator load” so that when mast cells do activate, the reaction stays manageable rather than spiraling into a crisis.

Living With MCAS

MCAS is a chronic condition, and its unpredictability is often as challenging as the symptoms themselves. People with MCAS frequently describe good days and bad days with no obvious explanation for the difference. Social situations, travel, and even routine medical or dental procedures can require extra planning because of the risk of unexpected reactions.

Many people with MCAS carry emergency medications, including injectable epinephrine, in case of anaphylaxis. Finding the right combination of daily medications often takes trial and error over weeks or months, since individual responses vary and some people react to inactive ingredients in medications themselves. Working with a clinician experienced in mast cell disorders, typically an allergist or immunologist, makes a significant difference in how quickly symptoms come under control.